Copyright Reports & Markets. All rights reserved.

Global Valsartan Drug Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Valsartan Drug

      • 1.1 Definition of Valsartan Drug
      • 1.2 Valsartan Drug Segment by Type
        • 1.2.1 Global Valsartan Drug Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 40 mg Tablets
        • 1.2.3 80 mg Tablets
        • 1.2.4 160 mg Tablets
        • 1.2.5 320 mg Tablets
      • 1.3 Valsartan Drug Segment by Applications
        • 1.3.1 Global Valsartan Drug Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hypertension
        • 1.3.3 Heart Failure
        • 1.3.4 Heart Attack
      • 1.4 Global Valsartan Drug Overall Market
        • 1.4.1 Global Valsartan Drug Revenue (2014-2025)
        • 1.4.2 Global Valsartan Drug Production (2014-2025)
        • 1.4.3 North America Valsartan Drug Status and Prospect (2014-2025)
        • 1.4.4 Europe Valsartan Drug Status and Prospect (2014-2025)
        • 1.4.5 China Valsartan Drug Status and Prospect (2014-2025)
        • 1.4.6 Japan Valsartan Drug Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Valsartan Drug Status and Prospect (2014-2025)
        • 1.4.8 India Valsartan Drug Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Valsartan Drug
      • 2.3 Manufacturing Process Analysis of Valsartan Drug
      • 2.4 Industry Chain Structure of Valsartan Drug

      3 Development and Manufacturing Plants Analysis of Valsartan Drug

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Valsartan Drug Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Valsartan Drug
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Valsartan Drug Production and Capacity Analysis
      • 4.2 Valsartan Drug Revenue Analysis
      • 4.3 Valsartan Drug Price Analysis
      • 4.4 Market Concentration Degree

      5 Valsartan Drug Regional Market Analysis

      • 5.1 Valsartan Drug Production by Regions
        • 5.1.1 Global Valsartan Drug Production by Regions
        • 5.1.2 Global Valsartan Drug Revenue by Regions
      • 5.2 Valsartan Drug Consumption by Regions
      • 5.3 North America Valsartan Drug Market Analysis
        • 5.3.1 North America Valsartan Drug Production
        • 5.3.2 North America Valsartan Drug Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Valsartan Drug Import and Export
      • 5.4 Europe Valsartan Drug Market Analysis
        • 5.4.1 Europe Valsartan Drug Production
        • 5.4.2 Europe Valsartan Drug Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Valsartan Drug Import and Export
      • 5.5 China Valsartan Drug Market Analysis
        • 5.5.1 China Valsartan Drug Production
        • 5.5.2 China Valsartan Drug Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Valsartan Drug Import and Export
      • 5.6 Japan Valsartan Drug Market Analysis
        • 5.6.1 Japan Valsartan Drug Production
        • 5.6.2 Japan Valsartan Drug Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Valsartan Drug Import and Export
      • 5.7 Southeast Asia Valsartan Drug Market Analysis
        • 5.7.1 Southeast Asia Valsartan Drug Production
        • 5.7.2 Southeast Asia Valsartan Drug Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Valsartan Drug Import and Export
      • 5.8 India Valsartan Drug Market Analysis
        • 5.8.1 India Valsartan Drug Production
        • 5.8.2 India Valsartan Drug Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Valsartan Drug Import and Export

      6 Valsartan Drug Segment Market Analysis (by Type)

      • 6.1 Global Valsartan Drug Production by Type
      • 6.2 Global Valsartan Drug Revenue by Type
      • 6.3 Valsartan Drug Price by Type

      7 Valsartan Drug Segment Market Analysis (by Application)

      • 7.1 Global Valsartan Drug Consumption by Application
      • 7.2 Global Valsartan Drug Consumption Market Share by Application (2014-2019)

      8 Valsartan Drug Major Manufacturers Analysis

      • 8.1 Novartis
        • 8.1.1 Novartis Valsartan Drug Production Sites and Area Served
        • 8.1.2 Novartis Product Introduction, Application and Specification
        • 8.1.3 Novartis Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sun Pharmaceutical
        • 8.2.1 Sun Pharmaceutical Valsartan Drug Production Sites and Area Served
        • 8.2.2 Sun Pharmaceutical Product Introduction, Application and Specification
        • 8.2.3 Sun Pharmaceutical Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Teva
        • 8.3.1 Teva Valsartan Drug Production Sites and Area Served
        • 8.3.2 Teva Product Introduction, Application and Specification
        • 8.3.3 Teva Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Mylan
        • 8.4.1 Mylan Valsartan Drug Production Sites and Area Served
        • 8.4.2 Mylan Product Introduction, Application and Specification
        • 8.4.3 Mylan Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Alembic Pharmaceuticals
        • 8.5.1 Alembic Pharmaceuticals Valsartan Drug Production Sites and Area Served
        • 8.5.2 Alembic Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Alembic Pharmaceuticals Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Lupin
        • 8.6.1 Lupin Valsartan Drug Production Sites and Area Served
        • 8.6.2 Lupin Product Introduction, Application and Specification
        • 8.6.3 Lupin Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Aurobindo Pharma
        • 8.7.1 Aurobindo Pharma Valsartan Drug Production Sites and Area Served
        • 8.7.2 Aurobindo Pharma Product Introduction, Application and Specification
        • 8.7.3 Aurobindo Pharma Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Macleods Pharmaceuticals
        • 8.8.1 Macleods Pharmaceuticals Valsartan Drug Production Sites and Area Served
        • 8.8.2 Macleods Pharmaceuticals Product Introduction, Application and Specification
        • 8.8.3 Macleods Pharmaceuticals Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 HETERO
        • 8.9.1 HETERO Valsartan Drug Production Sites and Area Served
        • 8.9.2 HETERO Product Introduction, Application and Specification
        • 8.9.3 HETERO Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Torrent Pharmaceuticals
        • 8.10.1 Torrent Pharmaceuticals Valsartan Drug Production Sites and Area Served
        • 8.10.2 Torrent Pharmaceuticals Product Introduction, Application and Specification
        • 8.10.3 Torrent Pharmaceuticals Valsartan Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Huaren Pharmaceutical
      • 8.12 Jubilant Pharma
      • 8.13 Amneal Pharmaceuticals
      • 8.14 Zhejiang Huahai Pharmaceutical
      • 8.15 Square Pharmaceuticals
      • 8.16 Unichem Laboratories

      9 Development Trend of Analysis of Valsartan Drug Market

      • 9.1 Global Valsartan Drug Market Trend Analysis
        • 9.1.1 Global Valsartan Drug Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Valsartan Drug Regional Market Trend
        • 9.2.1 North America Valsartan Drug Forecast 2019-2025
        • 9.2.2 Europe Valsartan Drug Forecast 2019-2025
        • 9.2.3 China Valsartan Drug Forecast 2019-2025
        • 9.2.4 Japan Valsartan Drug Forecast 2019-2025
        • 9.2.5 Southeast Asia Valsartan Drug Forecast 2019-2025
        • 9.2.6 India Valsartan Drug Forecast 2019-2025
      • 9.3 Valsartan Drug Market Trend (Product Type)
      • 9.4 Valsartan Drug Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Valsartan Drug Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Valsartan (trade name Diovan, Novartis International AG) is mainly used for treatment of high blood pressure, congestive heart failure, and to increase the chances of living longer after a heart attack. It is an angiotensin II receptor antagonist (commonly called an ARB, or angiotensin receptor blocker), that is selective for the type I (AT1) angiotensin receptor.

        The global Valsartan Drug market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Valsartan Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Valsartan Drug market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Valsartan Drug in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Valsartan Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Novartis
        Sun Pharmaceutical
        Teva
        Mylan
        Alembic Pharmaceuticals
        Lupin
        Aurobindo Pharma
        Macleods Pharmaceuticals
        HETERO
        Torrent Pharmaceuticals
        Huaren Pharmaceutical
        Jubilant Pharma
        Amneal Pharmaceuticals
        Zhejiang Huahai Pharmaceutical
        Square Pharmaceuticals
        Unichem Laboratories

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        40 mg Tablets
        80 mg Tablets
        160 mg Tablets
        320 mg Tablets

        Segment by Application
        Hypertension
        Heart Failure
        Heart Attack

        Buy now